Suppr超能文献

供体基线慢性肾损伤对心脏死亡供体(DCD)和脑死亡供体(DBD)肾脏的移植存活具有相同的不利影响。

Baseline donor chronic renal injury confers the same transplant survival disadvantage for DCD and DBD kidneys.

作者信息

Kosmoliaptsis V, Salji M, Bardsley V, Chen Y, Thiru S, Griffiths M H, Copley H C, Saeb-Parsy K, Bradley J A, Torpey N, Pettigrew G J

机构信息

Department of Surgery, University of Cambridge, and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

出版信息

Am J Transplant. 2015 Mar;15(3):754-63. doi: 10.1111/ajt.13009. Epub 2015 Jan 29.

Abstract

Histological assessment of baseline chronic kidney injury may discriminate kidneys that are suitable for transplantation, but has not been validated for appraisal of donation after circulatory death (DCD) kidneys. 'Time-zero' biopsies for 371 consecutive, solitary, deceased-donor kidneys transplanted at our center between 2006 and 2010 (65.5% DCD, 34.5% donation after brain death [DBD]) were reviewed and baseline chronic degenerative injury scored using Remuzzi's classification. High scores correlated with donor age and extended criteria donors (42% of donors), but the spectrum of scores was similar for DCD and DBD kidneys. Transplant outcomes for kidneys scoring from 0 to 4 were comparable (1 and 3 year graft survival 95% and 92%), but were much poorer for kidneys scoring ≥5, with 1 year graft survival only 73%, and 12.5% suffering primary nonfunction. Critically, high Remuzzi scores conferred the same survival disadvantage for DCD and DBD kidneys. On multi-variable regression analysis, time-zero biopsy score was the only independent predictor for graft survival, whereas one-year graft estimated glomerular filtration rate (eGFR) correlated with donor age and biopsy score. In conclusion, the relationship between severity of chronic kidney injury and transplant outcome is similar for DCD and DBD kidneys. Kidneys with Remuzzi scores of ≤4 can be implanted singly with acceptable results.

摘要

对基线慢性肾损伤进行组织学评估可能有助于鉴别适合移植的肾脏,但尚未在评估心脏死亡后捐赠(DCD)肾脏方面得到验证。对2006年至2010年间在我们中心连续移植的371个单独的死亡供体肾脏进行“零时”活检(65.5%为DCD,34.5%为脑死亡后捐赠[DBD]),并使用雷穆齐分类法对基线慢性退行性损伤进行评分。高分与供体年龄和扩展标准供体(占供体的42%)相关,但DCD和DBD肾脏的评分范围相似。评分为0至4分的肾脏移植结果相当(1年和3年移植肾存活率分别为95%和92%),但评分≥5分的肾脏结果要差得多,1年移植肾存活率仅为73%,12.5%发生原发性无功能。至关重要的是,雷穆齐高分对DCD和DBD肾脏具有相同的生存劣势。多变量回归分析显示,零时活检评分是移植肾存活的唯一独立预测因素,而1年移植肾估计肾小球滤过率(eGFR)与供体年龄和活检评分相关。总之,DCD和DBD肾脏慢性肾损伤严重程度与移植结果之间的关系相似。雷穆齐评分≤4分的肾脏可以单独植入,结果可接受。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验